证券代码：301092 证券简称：争光股份 公告编号：2023-049 浙江争光实业股份有限公司 关于变更公司注册资本、修订《公司章程》 并办理工商变更登记的公告 根据上述注册资本变更情况，以及《中华人民共和国公司法》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律 监管指引第 2 号——创业板上市公司规范运作》等有关法律、法规、 规范性文件的规定，公司拟对《公司章程》相应条款进行修订。具体 修订内容如下： | 修订前条款 | | 修订后条款 | | | --- | --- | --- | --- | | 第六条 | 公司注册资本为人民 | 第六条 | 公司注册资本为人民 | | 币 133,333,334 | 元。 | 币 133,693,484 | 元。 | | 第十九条 | 公司股份总数为 | 第十九条 | 公司股份总数为 | | 133,333,334 | 股，均为普通股。 | 133,693,484 | 股，均为普通股。 | 除上述修订条款外，《公司章程》中其他条款保持不变。修订后 的《公司章程》全文详见巨潮资讯网（www.cninfo.com.cn)。 三、其他事项 公司于 20 ...

证券代码：301092 证券简称：争光股份 公告编号：2023-051 浙江争光实业股份有限公司 关于聘任公司证券事务代表的公告 | 本公司及董事会全体成员保证信息披露内容的真实、准确和完 | | --- | | 整，没有虚假记载、误导性陈述或重大遗漏。 | 浙江争光实业股份有限公司（以下简称"公司"）于 2023 年 8 月 24 日召开第六届董事会第三次会议，审议通过了《关于聘任公司证 券事务代表的议案》，同意聘任车程先生为公司证券事务代表（简历 附后），协助董事会秘书开展相关工作，任期自本次董事会审议通过 之日起至第六届董事会届满之日止。 车程先生已通过深圳证券交易所上市公司董事会秘书资格考试 并取得了《董事会秘书资格证书》，其任职资格符合深圳证券交易所 《上市公司自律监管指引第 2 号—创业板上市公司规范运作》等有 关规定，不存在不适合任职的情形。车程先生未受过中国证监会及其 他有关部门的处罚和证券交易所的惩戒，不存在不得担任证券事务代 表的情形，不存在被中国证监会确定为市场禁入者且在禁入期的情况， 不属于失信被执行人。 车程先生的联系方式如下： 联系电话：0571-86319310 传 真：0571 ...

证券代码：301092 证券简称：争光股份 公告编号：2023-046 浙江争光实业股份有限公司 第六届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 浙江争光实业股份有限公司（以下简称"公司"）第六届董事会 第三次会议通知于 2023 年 8 月 14 日以电子邮件的方式送达至全体董 事。本次会议于 2023 年 8 月 24 日在公司会议室以现场结合通讯方式 召开。会议应出席董事 7 人，实际出席董事 7 人，其中董事劳法勇， 独立董事冯凤琴、肖连生、金浪以通讯方式出席会议。本次会议由董 事长沈建华先生召集并主持，公司监事、高级管理人员列席了本次董 事会。本次会议的召集、召开和表决程序符合《中华人民共和国公司 法》等法律法规和《公司章程》的有关规定，会议合法、有效。 二、董事会会议审议情况 会议审议并通过了如下议案： 1、审议通过《关于<2023 年半年度报告>全文及其摘要的议案》 全体与会董事认真审议了公司《2023年半年度报告》全文及其摘 要，认为公司《2023年半年度报告》真实、准确、完整地反映了公司 2023年半年度的财务 ...

2023 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 根据深圳证券交易所印发的《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》（深证上〔2022〕14 号）及相关格式指引的 规定，将浙江争光实业股份有限公司（以下简称"公司"）2023 年半年度募集 资金存放与使用情况报告如下： 证券代码：301092 证券简称：争光股份 公告编号：2023-048 浙江争光实业股份有限公司 一、募集资金基本情况 (一)实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意浙江争光实业股份有限公司首次公 开发行股票注册的批复》（证监许可〔2021〕2803 号），本公司由主承销商国 信证券股份有限公司采用采用向网下向符合条件的投资者询价配售和网上向持 有深圳市场非限售 A 股股份或非限售存托凭证市值的社会公众投资者定价发行 相结合的方式，向社会公众公开发行人民币普通股（A 股）股票 3,333.3334 万 股，发行价为每股人民币 36.31 元，共计募集资金 121,033.34 万元，坐扣 ...

证券代码：301092 证券简称：争光股份 公告编号：2023-047 浙江争光实业股份有限公司 第六届监事会第三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 浙江争光实业股份有限公司（以下简称"公司"）第六届监事会 第三次会议通知于 2023 年 8 月 14 日以电子邮件的方式送达至全体监 事。本次会议于 2023 年 8 月 24 日在公司会议室以现场结合通讯方式 召开。会议应参加监事 3 人，实际参加监事 3 人，会议由监事会主席 张翼先生召集并主持。本次会议的召集、召开和表决程序符合《中华 人民共和国公司法》和《浙江争光实业股份有限公司章程》（以下简 称"《公司章程》"）的有关规定，会议合法、有效。 二、监事会会议审议情况 会议审议并通过了如下议案： 1、审议通过《关于<2023 年半年度报告>全文及其摘要的议案》 表决结果：3 票同意、0 票反对、0 票弃权。 2、审议通过《关于公司<2023 年半年度募集资金存放与使用情 况的专项报告>的议案》 经审核，公司监事会认为：公司 2023 年半年度募集资金的存 ...

证券代码：301092 证券简称：争光股份 浙江争光实业股份有限公司 投资者关系活动记录表 编号：2023-001 特定对象调研 分析师会议 媒体采访 业绩说明会 投资者关系活动 新闻发布会 路演活动 类别 现场参观 其他（请文字说明其他活动内容） 参与单位名称及 通过全景网"投资者关系互动平台"（https://ir.p5w.net）参 人员姓名 与公司 2022 年度网上业绩说明会的投资者 时 间 2023 年 5 月 16 日(周二)下午 15:00～17:00 地 点 全景网"投资者关系互动平台"（https://ir.p5w.net） 1、董事长、总经理：沈建华 上市公司接待 2、副总经理、董事会秘书、财务负责人：吴雅飞 人员姓名 3、独立董事：金浪 4、保荐代表人：严凯 投资者提出的问题及公司回复情况 公司就投资者在本次说明会中提出的问题进行了回复： 1、请问荆门功能性高分子材料新生产基地在产品布局方面 主要侧重于哪些应用领域，有何意义？ 投资者关系活动 您好，荆门项目产品应用方向主要是新能源、环保、生物医 主要内容介绍 药领域，与宁波产能结构形成互补。公司将高标准规划设计荆门 功能性高分子材料新 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥117,831,217.78, a decrease of 8.71% compared to ¥129,075,104.49 in the same period last year[5] - Net profit attributable to shareholders was ¥20,642,891.60, representing a 4.36% increase from ¥19,781,114.86 year-on-year[5] - Total operating revenue for Q1 2023 was CNY 117,831,217.78, a decrease of 8.6% from CNY 129,075,104.49 in Q1 2022[20] - Net profit for Q1 2023 was CNY 20,642,891.60, representing an increase of 4.4% compared to CNY 19,781,114.86 in Q1 2022[21] - Earnings per share remained stable at CNY 0.15 for both Q1 2023 and Q1 2022[21] Cash Flow and Liquidity - The net cash flow from operating activities improved significantly to ¥13,007,678.27, a 234.82% increase from a negative cash flow of -¥9,648,046.19 in the previous year[5] - The total cash and cash equivalents at the end of Q1 2023 stood at ¥426,447,739.15, down from ¥754,936,012.06 at the beginning of the quarter, indicating a decrease in liquidity[24] - Total cash inflow from investment activities was ¥130,347,375.90, while cash outflow was ¥473,303,544.99, resulting in a net cash flow from investment activities of -¥342,956,169.09, showing a decrease in investment activity compared to the previous year[23] - The cash flow from financing activities showed a net inflow of ¥2,953,581.17, contrasting with a net outflow of ¥19,423,184.17 in Q1 2022, reflecting improved financing conditions[24] - The company received cash from the recovery of investments amounting to ¥119,000,000.00, which is lower than the ¥150,000,000.00 received in the same period last year[23] Assets and Liabilities - Total assets at the end of Q1 2023 reached ¥1,877,158,057.44, reflecting a 1.62% increase from ¥1,847,310,297.11 at the end of the previous year[5] - Total liabilities increased to CNY 141,077,450.41, up from CNY 135,048,312.61 in the previous year[20] - Total equity rose to CNY 1,736,080,607.03, compared to CNY 1,712,261,984.50 in Q1 2022[20] - Cash and cash equivalents decreased to CNY 641,318,933.21 from CNY 818,950,539.54, representing a decline of approximately 21.6%[17] Operational Efficiency - The company reported a significant increase in accounts receivable, which rose by 183.03% to ¥20,736,342.65 due to increased customer payments[9] - The company experienced a 130.22% increase in tax and additional fees, totaling ¥796,802.14, mainly due to increased VAT payable in Q1[9] - Total operating costs decreased to CNY 94,741,537.50, down 14.4% from CNY 110,576,889.73 in the previous year[20] - The cash outflow for purchasing goods and services was ¥58,984,883.34, a decrease from ¥71,932,141.75 in Q1 2022, suggesting improved cost management[23] Investments and Research - Investment income decreased by 75.83% to ¥1,584,806.03, attributed to reduced interest income from bank wealth management products[9] - Research and development expenses increased to CNY 4,720,839.29, up from CNY 3,783,483.67 in the previous year, indicating a focus on innovation[20] - The company did not report any cash inflow from new investments or significant acquisitions during this quarter, indicating a cautious approach to expansion[23] - The company has not disclosed any new product developments or market expansion strategies in the current report[15] Shareholder Information - The company reported a total of 97,843,475 shares under lock-up agreements, with no shares released during the reporting period[14] - The company has a significant amount of restricted shares, with the largest shareholder holding 69,480,000 shares under lock-up until May 2, 2025[14]

Financial Performance - The company's operating revenue for 2022 was RMB 676,040,494.39, representing a 49.78% increase compared to RMB 451,344,158.90 in 2021[21]. - The net profit attributable to shareholders for 2022 was RMB 177,824,990.70, a significant increase of 141.37% from RMB 73,673,340.64 in the previous year[21]. - The net cash flow from operating activities reached RMB 76,848,469.98, up 52.70% from RMB 50,327,085.47 in 2021[21]. - Basic earnings per share for 2022 were RMB 1.33, a 90.00% increase from RMB 0.70 in 2021[21]. - Total assets at the end of 2022 amounted to RMB 1,847,310,297.11, reflecting a 12.32% increase from RMB 1,644,621,182.85 at the end of 2021[21]. - The net assets attributable to shareholders at the end of 2022 were RMB 1,712,261,984.50, which is a 10.88% increase from RMB 1,544,284,419.74 in 2021[21]. - The company reported a weighted average return on equity of 10.93% for 2022, down from 12.47% in 2021[21]. - The net profit after deducting non-recurring gains and losses for 2022 was RMB 80,294,390.93, a 20.46% increase from RMB 66,657,635.21 in 2021[21]. Dividend Distribution - The company plans to distribute a cash dividend of RMB 1.20 per 10 shares, totaling approximately RMB 16,000,000 based on 133,333,334 shares[3]. - The company distributed a cash dividend of 1.20 CNY per 10 shares, totaling 16,000,000.08 CNY, which represents 100% of the total profit distribution[159]. - The total distributable profit for the period was 336,747,882.17 CNY[159]. - The company has a cash dividend policy that mandates a minimum distribution of 20% of the distributable profit if cash flow is sufficient and there are no major capital expenditures planned in the next twelve months[196]. - The profit distribution decision will consider the opinions of independent directors and public investors[195]. Research and Development - The company emphasizes R&D innovation and holds numerous patents, positioning itself as a high-tech enterprise in the industry[34]. - The company applied for 5 new invention patents in 2022, demonstrating its commitment to innovation in the ion exchange resin industry[35]. - R&D investment amounted to CNY 23.22 million, representing 3.43% of operating revenue, focusing on new product and process development[58]. - The number of R&D personnel increased by 16.28% from 43 in 2021 to 50 in 2022, with a higher proportion of staff holding bachelor's degrees[70]. - The company has a total of 50 R&D personnel, accounting for 15.38% of the total workforce, and holds 21 patents, including 13 invention patents and 8 utility model patents[51]. Market Position and Strategy - The company is a leading domestic producer of ion exchange and adsorption resins, with products exported to multiple countries including Germany, Switzerland, and the USA[34]. - The ion exchange and adsorption resin industry is experiencing increased demand due to applications in high-end industrial water, food safety, and environmental protection[32]. - The company has established a strong customer base, including major firms like BRITA and Mitsubishi Chemical, enhancing its market presence[34]. - The company is focused on expanding its product applications in new fields, driven by the growing market needs and technological advancements[34]. - The company has achieved a market growth of over 40% in the application of ion exchange and adsorption resins in the environmental protection industry, particularly in VOCs and CO2 adsorption[45]. Production and Operations - The design capacity for ion exchange and adsorption resins is 19,750 tons, with a capacity utilization rate of 101%[49]. - The company has completed 100% of the construction progress for a 2,300-ton large pore adsorption resin project and 40% for a 15,000-ton food-grade and refined treatment resin project[49]. - The production process utilizes advanced DCS systems for automated control, ensuring consistent product quality across different batches[42]. - The company employs a research and development model focused on both independent and collaborative efforts, emphasizing new product and application development[40]. Environmental Responsibility - The company has implemented environmental protection measures in compliance with national standards, with a valid pollution discharge permit effective until October 24, 2026[174]. - The company reported a total COD discharge of 56.02 mg/L, which is below the standard limit of 60.95 mg/L, indicating compliance with environmental regulations[175]. - The company has established a comprehensive environmental protection system and has obtained ISO 14001:2015 environmental management system certification[179]. - The company invested 4.0822 million yuan in environmental protection-related expenses during the reporting period[179]. - The company replaced forklifts with electric ones to significantly reduce diesel usage and is gradually phasing out old motors for energy-efficient ones[179]. Corporate Governance - The company has established a comprehensive corporate governance structure, including a shareholders' meeting, board of directors, and supervisory board[125]. - The company actively respects and maintains the legitimate rights and interests of stakeholders, ensuring balanced benefits for shareholders, employees, and society[120]. - The company has implemented a strict information disclosure management system to prevent the leakage of undisclosed information[119]. - The company has a dedicated financial department that operates independently, adhering to relevant laws and regulations for financial decision-making[124]. - The company has established a comprehensive performance evaluation and incentive mechanism for its directors and senior management[117]. Risk Management - The company has acknowledged potential risks in its future development outlook, which investors should be aware of[3]. - The company faces raw material price fluctuation risks, with raw material costs significantly impacting gross margins, and plans to mitigate this through advance contracts and price negotiations[107]. - The company anticipates increased market competition and aims to continuously develop new products and expand into high-value markets, particularly in food, pharmaceuticals, and environmental sectors[108]. Employee Development - The company provided training for all employees, including safety education and specialized skills training, with a minimum of 16 hours of online training per employee[157]. - The company has implemented a strict salary system in accordance with national laws, including five social insurances and one housing fund for each employee[155]. - The company emphasizes employee development through various training programs, enhancing operational skills and management capabilities[186]. Shareholder Relations - The company actively engages with investors through various communication channels, including investor relations platforms[112]. - The company emphasizes fair treatment of all shareholders, providing convenient access to participate in meetings and exercise their rights[116]. - The company will ensure that any profit distribution does not exceed the cumulative distributable profit[195]. Future Outlook - The company aims to become an "internationally leading manufacturer of ion exchange and adsorption resins" and will enhance product quality and brand image[102]. - The company plans to invest in R&D, purchasing advanced equipment and improving the R&D environment, while also attracting high-quality talent[103]. - The company will accelerate project construction to expand production capacity, including a 2,300-ton annual production line for macroporous adsorption resins and a 15,000-ton food-grade resin production line[104].

浙江争光实业股份有限公司 证券代码：301092 证券简称：争光股份 公告编号：2023-009 关于举行 2022 年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 浙江争光实业股份有限公司（以下简称"公司"）于 2023 年 4 月 21 日披露了《2022 年年度报告》。为便于广大投资者更深入全面 地了解公司情况，进一步加强与投资者的沟通，做好投资者关系管理 工作，公司拟定于 2023 年 5 月 16 日（星期二）下午 15：00-17:00 在全景网举办 2022 年度业绩说明会。本次年度业绩说明会将采用网 络远程的方式举行，投资者可登陆全景网"投资者关系互动平台" （http://ir.p5w.net）参与本次年度业绩说明会。 出席本次业绩说明会的人员有：公司董事长、总经理沈建华先生， 副总经理、董事会秘书、财务负责人吴雅飞女士，独立董事金浪先生， 保荐代表人严凯先生。 为充分尊重投资者、提升交流的针对性，广泛听取投资者的意见 和建议，现就公司 2022 年度业绩说明会提前向投资者公开征集问题。 投 资 者 可 于 2023 ...

证券代码：301092 证券简称：争光股份 浙江争光实业股份有限公司 投资者关系活动记录表 编号：2022-003 | --- | --- | |----------------|-----------------------------------------------------------------------------| | | | | 投资者关系活动 | 特定对象调研 □分析师会议 | | 类别 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | | | | （请文字说明其他活动内容） | | 参与单位名称及 | 华安证券股份有限公司 单明、 | | 人员姓名 | 杭州金雕资产管理有限公司 滕金校、 | | | 杭州常嘉资产管理有限公司 徐振杨、 | | | 浙江白蓝私募基金管理有限公司 李东亚、陈盛、 | | | 浙江浙商证券资产管理有限公司 叶方强、 | | | | | | 上海景淳投资管理有限公司 吴祺、 | | | 杭州新干懋业私募基金管理有限公司 史佳立、 | | | 杭州瑶珈投资管理合伙企业(有限合伙 ) 周露 | | 时间 | 19 日 10:00-1 ...